These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34072635)

  • 21. Resource Management through Artificial Intelligence in Screening Programs-Key for the Successful Elimination of Hepatitis C.
    Butaru AE; Mămuleanu M; Streba CT; Doica IP; Diculescu MM; Gheonea DI; Oancea CN
    Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
    Braun DL; Hampel B; Ledergerber B; Grube C; Nguyen H; Künzler-Heule P; Shah C; Salazar-Vizcaya L; Conen A; Flepp M; Stöckle M; Béguelin C; Schmid P; Rougemont M; Delaloye J; Bernasconi E; Nicca D; Böni J; Rauch A; Kouyos RD; Günthard HF; Fehr JS
    Clin Infect Dis; 2021 Oct; 73(7):e2194-e2202. PubMed ID: 32761122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness.
    Rajkumar N; Khumukcham LS; Thangjam D; Singh S; Khwairakpam G; Shilton S; Goel A
    Harm Reduct J; 2024 May; 21(1):98. PubMed ID: 38769517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
    Tsertsvadze T; Gamkrelidze A; Chkhartishvili N; Abutidze A; Sharvadze L; Kerashvili V; Butsashvili M; Metreveli D; Gvinjilia L; Shadaker S; Nasrullah M; Adamia E; Zeuzem S; Afdhal N; Arora S; Thornton K; Skaggs B; Kuchuloria T; Lagvilava M; Sergeenko D; Averhoff F
    Clin Infect Dis; 2020 Aug; 71(5):1263-1268. PubMed ID: 31563938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
    Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
    Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
    Hasan F; Alfadhli A; Al-Gharabally A; Alkhaldi M; Colombo M; Lazarus JV
    World J Gastroenterol; 2020 Aug; 26(30):4415-4427. PubMed ID: 32874054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population.
    Mongale E; Allen S; Brew I; Ludlow-Rhodes A; Royal N; Waldron J; Alexander H; Christensen L; Dorrington K; Milner A; Missen L; Jones A; Troke PJF
    JHEP Rep; 2024 Jan; 6(1):100937. PubMed ID: 38169900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.
    Mera J; Williams MB; Essex W; McGrew KM; Boeckman L; Gahn D; Miller A; Durham D; Fox J; David C; Ritter T; Jones S; Bouse S; Galvani A; Ward JW; Drevets DA; Carabin H
    JAMA Netw Open; 2020 Dec; 3(12):e2030427. PubMed ID: 33337496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus micro-elimination: Where do we stand?
    Mangia A; Cotugno R; Cocomazzi G; Squillante MM; Piazzolla V
    World J Gastroenterol; 2021 Apr; 27(16):1728-1737. PubMed ID: 33967553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient-centered program from Italy.
    Mangia A; Rina MF; Canosa A; Piazzolla V; Squillante MM; Agostinacchio E; Cocomazzi G; Visaggi E; Augello N; Iannuzziello C; Falcone M; De Giorgi A; Campanozzi F
    United European Gastroenterol J; 2021 Dec; 9(10):1109-1118. PubMed ID: 34697911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine screening for hepatitis C viral infection in patients undergoing elective cranial neurosurgery.
    Nussbaum ES; Kallmes K; Lowary J; Nussbaum LA
    J Neurosurg; 2019 Sep; 131(3):941-948. PubMed ID: 30215562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
    Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
    Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study.
    Kracht PAM; de Gee EA; van der Poel A; Verhagen MAMT; Hoepelman AIM; Croes EA; Arends JE
    Harm Reduct J; 2019 Jul; 16(1):45. PubMed ID: 31307470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study.
    Chang TS; Chang KC; Chen WM; Hsu NT; Lee CY; Lin YC; Huang WC; Chiu WN; Hu JH; Huang TJ; Chen MY; Lu SN
    BMJ Open; 2021 Jul; 11(7):e046115. PubMed ID: 34233977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol.
    Arif A; Hasnain A; Chaudhry A; Asim M; Shafqat MN; Altaf A; Saba N; Kemos P; Ansari MA; Barnes E; Metcalfe C; Vickerman P; Qureshi H; Hamid S; Choudhry AA; Niaz SK; Foster GR; Choudhry N
    BMC Public Health; 2023 Dec; 23(1):2529. PubMed ID: 38110885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
    Stvilia K; Vephkvadze N; Gamkrelidze A; Khonelidze I; Getia V; Tsereteli M; Gvinjilia L; Kuchuloria T
    Public Health; 2021 Jun; 195():42-50. PubMed ID: 34051674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro-elimination of hepatitis C virus.
    Hollande C; Parlati L; Pol S
    Liver Int; 2020 Feb; 40 Suppl 1():67-71. PubMed ID: 32077601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.